Gaviscon for gastro-oesophageal reflux in infants: a poorly effective treatment?
- PMID: 16371388
- PMCID: PMC2083097
- DOI: 10.1136/adc.2005.086355
Gaviscon for gastro-oesophageal reflux in infants: a poorly effective treatment?
Conflict of interest statement
Competing interests: none declared
Comment on
-
Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance/pH.Arch Dis Child. 2005 May;90(5):460-3. doi: 10.1136/adc.2002.024463. Arch Dis Child. 2005. PMID: 15851425 Free PMC article. Clinical Trial.
References
-
- Buts J P, Barudi C, Otte J B. Double‐blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children. Eur J Pediatr 1987146156–158. - PubMed
-
- Schilter B, Le Coultre C, Belli D C. Gastro‐oesophageal reflux in children: comparison of different durations, positions and sleep‐awake periods of pH monitoring in the same patient. Eur J Pediatr 1993152880–883. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical